EN PL

GMP: WHO publishes revised draft on the Guideline on \"Hold Time\" studies

10.04.2014
The key message of the Guideline has remained unchanged: manufacture in compliance with GMP requires the definition of hold times for intermediates and bulk products. The scope stated is the manufacture of solid dosage forms but it can also be applied to liquids and semi-solid dosage forms.